STRENZA PLUS
Generic: Moxifloxacin 0.5%, Bromfenac 0.09%, Prednisolone Acetate 1%
- Manufacturer
- Zuventus Healthcare Ltd
- NDC
- 73614-732
- RxCUI
- 403818
- Route
- OPHTHALMIC
- ICD-10 indication
- E55.9
Affordability Check
How much will you actually pay for STRENZA PLUS?
In 30 seconds, see every legitimate way to afford STRENZA PLUS — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About STRENZA PLUS
Strenza is a prescription medication indicated for the management of neuropathic pain. It is a combination formulation containing pregabalin and methylcobalamin. Pregabalin binds to calcium channels in the central nervous system to reduce pain signaling, while methylcobalamin (Vitamin B12) supports nerve regeneration and maintenance.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Moxifloxacin 0.5%, Bromfenac 0.09%, Prednisolone Acetate 1%.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup STRENZA PLUS →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Moxifloxacin 0.5%, Bromfenac 0.09%, Prednisolone Acetate 1% →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How STRENZA PLUS appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).
Covered by plans
71%
3,905 of 5,509 plans
Most common tier
Tier 2
On 34% of covering formularies
Prior authorization required
0%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 80 | 25% |
| Tier 2 (generic) | 110 | 34% |
| Tier 3 (preferred brand) | 80 | 25% |
| Tier 4 (non-preferred brand) | 55 | 17% |
Step therapy: 0% of formularies
Quantity limits: 29% of formularies
Coverage breadth: 325 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
BP Vit 3
Treats same condition · folic acid, pyridoxine hydrochloride, cyanocobalamin, omega-3 fatty acids, doconexent, icosapent and .beta.-sitosterol
Allday 5000 Sensitive
Treats same condition · 1.1% Sodium Fluoride Toothpaste
FOSAMAX PLUS D
Treats same condition · ALENDRONATE SODIUM and CHOLECALCIFEROL
Foltira
Treats same condition · Folate, Vitamin D3
Tri-Vite Drops with Fluoride
Treats same condition
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.